跳到主要內容

Krishnan Krish S 的 Form 4 申報

Krystal Biotech, Inc.(KRYS),2023/9/12 申報

申報編號
0001298709-23-000020
申報時間
2023/9/12
交易日
2023/9/11
申報延遲
1 天
10b5-1 計畫
有勾選

這份申報列了 10 筆非衍生性交易。公開市場賣出合計 $636.2 萬。交易後 1 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Krishnan Krish SCIK 0001298709董事、高階主管(總裁、執行長)、持股 10% 以上大股東

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2023/9/11Common StockS賣出處分−5,008$125.23F2−$627,151.841,679,330直接
2023/9/11Common StockS賣出處分−5,452$126.17F3−$687,878.841,673,878直接
2023/9/11Common StockS賣出處分−1,873$127.18F4−$238,208.141,672,005直接
2023/9/11Common StockS賣出處分−10,557$128.37F5−$1,355,202.091,661,448直接
2023/9/11Common StockS賣出處分−2,110$129.10F6−$272,4011,659,338直接
2023/9/11Common StockS賣出處分−5,007$125.23F2−$627,026.611,619,199間接
2023/9/11Common StockS賣出處分−5,452$126.17F3−$687,878.841,613,747間接
2023/9/11Common StockS賣出處分−1,874$127.18F4−$238,335.321,611,873間接
2023/9/11Common StockS賣出處分−10,557$128.37F5−$1,355,202.091,601,316間接
2023/9/11Common StockS賣出處分−2,110$129.10F6−$272,4011,599,206間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

The transaction was executed in multiple trades ranging from $124.7100 to $125.6950. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

表 I 有 2 筆交易的價格引用這則附註。

F3

The transaction was executed in multiple trades ranging from $125.7200 to $126.6800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

表 I 有 2 筆交易的價格引用這則附註。

F4

The transaction was executed in multiple trades ranging from $126.7200 to $127.7100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

表 I 有 2 筆交易的價格引用這則附註。

F5

The transaction was executed in multiple trades ranging from $127.7350 to $128.7300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

表 I 有 2 筆交易的價格引用這則附註。

F6

The transaction was executed in multiple trades ranging from $128.7400 to $129.4200. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

表 I 有 2 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)